SAR of a new antischistosomal urea carboxylic acid |
| |
Authors: | Jianbo Wu Chunkai Wang Cécile Häberli Karen L. White David M. Shackleford Gong Chen Yuxiang Dong Susan A. Charman Jennifer Keiser Jonathan L. Vennerstrom |
| |
Affiliation: | 1. College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE, United States;2. Department of Medical Parasitology and Infection Biology, Swiss Tropical Institute, Socinstrasse 57, CH-4002 Basel, Switzerland;3. University of Basel, CH-4003 Basel, Switzerland;4. Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia |
| |
Abstract: | Urea carboxylic acids, products of aryl hydantoin hydrolysis, were recently identified as a new antischistosomal chemotype. We now describe a baseline structure–activity relationship (SAR) for this compound series. With one exception, analogs of lead urea carboxylic acid 2 were quite polar with Log?D7.4 values ranging from ?1.9 to 1.8, had high aqueous solubilities in the range of 25–100?µg/mL, and were metabolically stable. None of the compounds had measurable in vitro antischistosomal activity or cytotoxicity, but four of these had moderate worm burden reduction (WBR) values of 42–70% when they were administered as single 100?mg/kg oral doses to S. mansoni-infected mice. These data indicate that with the exception of the gem-dimethyl substructure and the distal nitrogen atom of the urea functional group, the rest of the structure of 2 is required for in vivo antischistosomal activity. |
| |
Keywords: | Urea carboxylic acid Antischistosomal SAR |
本文献已被 ScienceDirect 等数据库收录! |
|